Exec-Edge, Author at ExecEdge - Page 17 of 139

CareDx to Acquire Naveris to Expand Into Cancer MRD Testing

CareDx to Acquire Naveris to Expand Into Cancer MRD Testing

By Daniella Parra CareDx (Nasdaq: CDNA) said it signed a definitive agreement to acquire Naveris, a commercial-stage precision oncology diagnostics company, for up to $260 million and will close in the third quarter. Naveris makes NavDx, a blood-based test that...

2U Refinances and Raises Growth Capital

2U Refinances and Raises Growth Capital

By Exec Edge Editorial Staff Many education technology companies spent 2024 and 2025 scaling back. New university partnerships slowed as institutions built internal capacity. Against that backdrop, 2U completed a growth recapitalization, with its existing owners putting growth capital into...

Nanox To Deploy 300 Nanox.ARC Systems in The U.S. Over 3 Years

Nanox To Deploy 300 Nanox.ARC Systems in The U.S. Over 3 Years

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it started two new U.S. collaborations to position its digital tomosynthesis system Nanox.ARC across the country. The first partnership is with Howard Technology Solutions to utilize 300 Nanox.ARC over a period...

Input your search keywords and press Enter.